These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31522376)

  • 1. Acceptance of Self-Sampling Among Long-Term Cervical Screening Non-Attenders with HPV-Positive Results: Promising Opportunity for Specific Cancer Education.
    Andersson S; Belkić K; Mints M; Östensson E
    J Cancer Educ; 2021 Feb; 36(1):126-133. PubMed ID: 31522376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders.
    Lam JUH; Elfström KM; Ejegod DM; Pedersen H; Rygaard C; Rebolj M; Lynge E; Juul KE; Kjær SK; Dillner J; Bonde J
    Br J Cancer; 2018 Jan; 118(1):138-144. PubMed ID: 29136403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of sending a direct send HPV self-sampling kit to long-term non-attenders in an organized cervical screening program.
    Sahlgren H; Sparén P; Elfgren K; Miriam Elfström K
    Eur J Obstet Gynecol Reprod Biol; 2022 Jan; 268():68-73. PubMed ID: 34875556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme.
    Bokan T; Ivanus U; Jerman T; Takac I; Arko D
    Radiol Oncol; 2021 Jan; 55(2):187-195. PubMed ID: 33764704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial.
    Szarewski A; Cadman L; Mesher D; Austin J; Ashdown-Barr L; Edwards R; Lyons D; Walker J; Christison J; Frater A; Waller J
    Br J Cancer; 2011 Mar; 104(6):915-20. PubMed ID: 21343937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability of self-sampling and human papillomavirus testing among non-attenders of cervical cancer screening programs in El Salvador.
    Maza M; Melendez M; Masch R; Alfaro K; Chacon A; Gonzalez E; Soler M; Conzuelo-Rodriguez G; Gage JC; Alonzo TA; Castle PE; Felix JC; Cremer M
    Prev Med; 2018 Sep; 114():149-155. PubMed ID: 29958860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial.
    Aasbø G; Tropè A; Nygård M; Christiansen IK; Baasland I; Iversen GA; Munk AC; Christiansen MH; Presthus GK; Undem K; Bjørge T; Castle PE; Hansen BT
    Br J Cancer; 2022 Nov; 127(10):1816-1826. PubMed ID: 35995936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is self-sampling to test for high-risk papillomavirus an acceptable option among women who have been treated for high-grade cervical intraepithelial neoplasia?
    Andersson S; Belkić K; Mints M; Östensson E
    PLoS One; 2018; 13(6):e0199038. PubMed ID: 29912903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sectional study of HPV testing in self-sampled urine and comparison with matched vaginal and cervical samples in women attending colposcopy for the management of abnormal cervical screening.
    Sargent A; Fletcher S; Bray K; Kitchener HC; Crosbie EJ
    BMJ Open; 2019 Apr; 9(4):e025388. PubMed ID: 31036707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer.
    Gyllensten U; Sanner K; Gustavsson I; Lindell M; Wikström I; Wilander E
    Br J Cancer; 2011 Aug; 105(5):694-7. PubMed ID: 21811250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women.
    Nobbenhuis MA; Helmerhorst TJ; van den Brule AJ; Rozendaal L; Jaspars LH; Voorhorst FJ; Verheijen RH; Meijer CJ
    J Clin Pathol; 2002 Jun; 55(6):435-9. PubMed ID: 12037026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A feasibility study on cervical screening in non-attenders invited to undergo HPV self-sampling with cytology triage versus repeat invitation for cytology screening in Hokkaido].
    Taniguchi S; Sakuragi N; Hanley SJB; Tsukiyama K; Fujita H; Sagae S; Kajii N; Watari H; Tamakoshi A
    Nihon Koshu Eisei Zasshi; 2021 Dec; 68(11):719-727. PubMed ID: 34373426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised trial of HPV self-sampling among non-attenders in the Slovenian cervical screening programme ZORA: comparing three different screening approaches.
    Ivanus U; Jerman T; Fokter AR; Takac I; Prevodnik VK; Marcec M; Gajsek US; Pakiz M; Koren J; Celik SH; Kramberger KG; Klopcic U; Kavalar R; Zatler SS; Kuzmanov BG; Florjancic M; Nolde N; Novakovic S; Poljak M; Zakelj MP
    Radiol Oncol; 2018 Sep; 52(4):399-412. PubMed ID: 30216191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study.
    El-Zein M; Bouten S; Louvanto K; Gilbert L; Gotlieb W; Hemmings R; Behr MA; Franco EL;
    Gynecol Oncol; 2018 Jun; 149(3):491-497. PubMed ID: 29678360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-sampling of vaginal fluid and high-risk human papillomavirus testing in women aged 50 years or older not attending Papanicolaou smear screening.
    Lindell M; Sanner K; Wikström I; Wilander E
    BJOG; 2012 Jan; 119(2):245-8. PubMed ID: 22017806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective cohort study examining cervical cancer screening methods in HIV-positive and HIV-negative Cambodian Women: a comparison of human papilloma virus testing, visualization with acetic acid and digital colposcopy.
    Thay S; Goldstein A; Goldstein LS; Govind V; Lim K; Seang C
    BMJ Open; 2019 Feb; 9(2):e026887. PubMed ID: 30804036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.
    Sellors JW; Lorincz AT; Mahony JB; Mielzynska I; Lytwyn A; Roth P; Howard M; Chong S; Daya D; Chapman W; Chernesky M
    CMAJ; 2000 Sep; 163(5):513-8. PubMed ID: 11006761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study.
    Gök M; Heideman DA; van Kemenade FJ; Berkhof J; Rozendaal L; Spruyt JW; Voorhorst F; Beliën JA; Babovic M; Snijders PJ; Meijer CJ
    BMJ; 2010 Mar; 340():c1040. PubMed ID: 20223872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program.
    Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
    BMC Cancer; 2016 Nov; 16(1):835. PubMed ID: 27809810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mailing human papillomavirus self-sampling kits to women under-screened for cervical cancer improved detection in cervical cancer screening in a general population study in Japan.
    Nishimura Y; Matsuura M; Terada N; Nagao S; Shimada H; Isoyama K; Tamate M; Iwasaki M; Saito T
    BMC Public Health; 2023 Mar; 23(1):473. PubMed ID: 36906527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.